Medpace (MEDP) Stock Insights
MEDP$688.00+14.21 +2.11%
$19.24B
Market Cap
36.86
P/E
37.90
Forward P/E
47
Score
Medpace (MEDP) Stock Insights
MEDP price $688.00 +14.21 +2.11%
- Ticker
- MEDP
- Price
- $688.00
- Change
- +14.21 +2.11%
- Market cap ?
- $19.24B
- P/E ?
- 36.86
- Forward P/E ?
- 37.90
- Dividend yield ?
- 0.00%
- Beta ?
- 1.18
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 47
- Value
- 14
- Quality
- 69
- Growth
- 58
Stocklytics score rationale: value 14, quality 69, growth 58.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 421582000 | 436152000 | 704589000 | 860969000 | 925925000 | 1142377000 | 1459996000 | 1885842000 | 2109054000 | 2530234000 |
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV…
Fair value
MEDP fair value $560.90. Price $688.00. Price is 23% above fair value.
Above fair value, and more expensive than usual. A larger premium than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 667.63M. Growth 11.72%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.80% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 27.97M. Net debt -360.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-08 | — | 4.82 | — | 718.40M |
| 2026-10-21 | 4.84 | 4.44 | 716.00M | 714.47M |
| 2026-07-22 | 4.25 | 3.98 | 707.33M | 689.51M |
| 2026-04-22 | 4.28 | 3.92 | 706.60M | 697.60M |
| 2026-02-09 | 4.67 | 4.19 | 708.45M | 689.31M |
| 2025-10-22 | 3.86 | 3.53 | 659.90M | 641.00M |
| 2025-07-21 | 3.10 | 2.98 | 603.31M | 538.77M |
| 2025-04-21 | 3.67 | 3.06 | 558.57M | 526.34M |
| 2025-02-10 | 3.67 | 2.96 | 536.59M | 539.74M |
| 2024-10-21 | 3.01 | 2.78 | 533.32M | 534.88M |
| 2024-07-22 | 2.75 | 2.54 | 528.10M | 528.40M |
| 2024-04-22 | 3.20 | 2.47 | 511.04M | 512.39M |
| 2024-02-12 | 2.46 | 2.22 | 498.40M | 512.06M |
| 2023-10-23 | 2.22 | 2.05 | 492.50M | 475.75M |
| 2023-07-24 | 1.93 | 1.91 | 460.87M | 448.29M |
| 2023-04-24 | 2.27 | 1.80 | 434.07M | 419.76M |
| 2023-02-13 | 2.12 | 1.79 | 394.10M | 386.01M |
| 2022-10-24 | 2.05 | 1.47 | 383.74M | 357.17M |
| 2022-07-25 | 1.46 | 1.31 | 351.21M | 344.01M |
| 2022-04-25 | 1.69 | 1.26 | 330.95M | 327.09M |
| 2022-02-14 | 1.32 | 1.25 | 308.55M | 309.04M |
| 2021-10-25 | 1.29 | 1.07 | 295.57M | 292.15M |
| 2021-07-26 | 1.06 | 0.99 | 278.29M | 292.15M |
| 2021-04-26 | 1.14 | 1.00 | 259.96M | 223.57M |
| 2021-02-15 | 1.35 | 1.24 | 259.68M | 236.64M |
| 2020-10-26 | 1.09 | 1.07 | 230.37M | 226.15M |
| 2020-07-27 | 0.68 | 0.41 | 205.00M | 131.32M |
| 2020-04-28 | 0.80 | 0.75 | 230.88M | 227.84M |
| 2020-02-24 | 0.85 | 0.75 | 229.89M | 202.84M |
| 2019-10-28 | 0.71 | 0.71 | 216.24M | 216.24M |
| 2019-07-29 | 0.81 | 0.64 | 214.10M | 169.17M |
| 2019-04-29 | 0.64 | 0.60 | 200.74M | 188.19M |
| 2019-02-25 | 0.76 | 0.67 | 192.12M | 169.36M |
| 2018-10-29 | 0.67 | 0.62 | 179.25M | 165.88M |
| 2018-07-30 | 0.61 | 0.42 | 170.14M | 117.15M |
| 2018-04-30 | 0.60 | 0.43 | 163.08M | 130.46M |
| 2018-02-26 | 0.39 | 0.38 | 112.68M | 109.79M |
| 2017-10-30 | 0.40 | 0.36 | 110.64M | 99.58M |
| 2017-07-31 | 0.38 | 0.30 | 106.22M | 83.85M |
| 2017-05-01 | 0.34 | 0.37 | 106.61M | 116.02M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-21 | BURWIG SUSAN E | Buy | 2.70K | $166.73 | 450.17K |
| 2026-10-21 | BURWIG SUSAN E | Sell | 2.70K | $166.73 | 450.17K |
| 2026-10-12 | BURWIG SUSAN E | Buy | 3.00K | $166.73 | 500.19K |
| 2026-10-12 | BURWIG SUSAN E | Sell | 3.00K | $166.73 | 500.19K |
| 2026-10-07 | BURWIG SUSAN E | Buy | 2.00K | $166.73 | 333.46K |
| 2026-10-07 | BURWIG SUSAN E | Sell | 2.00K | $166.73 | 333.46K |
| 2026-09-30 | McCarthy Cornelius P. III | Buy | 28 | — | — |
| 2026-09-30 | McCarthy Cornelius P. III | Sell | 28 | — | — |
| 2026-09-30 | Kraft Robert O. | Buy | 32 | — | — |
| 2026-09-30 | Kraft Robert O. | Sell | 32 | — | — |
| 2026-09-30 | Carley Brian T | Buy | 36 | — | — |
| 2026-09-30 | Carley Brian T | Sell | 36 | — | — |
| 2026-09-30 | Troendle August J. | Sell | 21.97K | $625.47 | 13.74M |
| 2026-09-29 | Troendle August J. | Sell | 26.70K | $621.02 | 16.58M |
| 2026-09-28 | Troendle August J. | Sell | 2.41K | $620.07 | 1.49M |
| 2026-09-25 | Troendle August J. | Sell | 154 | $620.60 | 95.57K |
| 2026-09-24 | Troendle August J. | Sell | 27.83K | $621.33 | 17.29M |
| 2026-09-23 | Troendle August J. | Sell | 16.08K | $628.64 | 10.11M |
| 2026-09-22 | Troendle August J. | Sell | 49.02K | $628.11 | 30.79M |
| 2026-09-21 | Troendle August J. | Sell | 21.88K | $623.29 | 13.64M |
| 2026-09-17 | Troendle August J. | Sell | 10.88K | $620.40 | 6.75M |
| 2026-09-16 | Troendle August J. | Sell | 8.77K | $621.29 | 5.45M |
| 2026-09-15 | Troendle August J. | Sell | 15.97K | $620.84 | 9.92M |
| 2026-09-15 | BURWIG SUSAN E | Buy | 3.00K | $166.73 | 500.19K |
| 2026-09-15 | BURWIG SUSAN E | Sell | 3.00K | $166.73 | 500.19K |
| 2026-08-27 | Troendle August J. | Sell | 650 | $620.27 | 403.18K |
| 2026-08-26 | Kraft Robert O. | Buy | 3.86K | $84.36 | 325.46K |
| 2026-08-26 | Kraft Robert O. | Sell | 3.86K | $617.81 | 2.38M |
| 2026-08-26 | Kraft Robert O. | Sell | 3.86K | $84.36 | 325.46K |
| 2026-08-26 | Troendle August J. | Sell | 4.00K | $620.03 | 2.48M |
| 2026-08-25 | Troendle August J. | Sell | 673 | $620.38 | 417.52K |
| 2026-08-24 | Troendle August J. | Sell | 1.98K | $620.23 | 1.23M |
| 2026-08-21 | Troendle August J. | Sell | 13.99K | $624.45 | 8.74M |
| 2026-08-20 | Brady Kevin M. | Buy | 3.40K | $138.87 | 472.16K |
| 2026-08-20 | Brady Kevin M. | Sell | 3.40K | $625.24 | 2.13M |
| 2026-08-20 | Brady Kevin M. | Sell | 3.40K | $138.87 | 472.16K |
| 2026-08-20 | Troendle August J. | Sell | 27.17K | $618.79 | 16.81M |
| 2026-08-19 | Troendle August J. | Sell | 15.61K | $606.47 | 9.47M |
| 2026-08-19 | Carley Brian T | Sell | 5.00K | $608.63 | 3.04M |
| 2026-08-19 | DAVENPORT FRED B JR | Buy | 1.82K | $164.68 | 300.05K |
| 2026-08-19 | DAVENPORT FRED B JR | Buy | 3.86K | $84.36 | 325.46K |
| 2026-08-19 | DAVENPORT FRED B JR | Buy | 1.90K | $133.87 | 254.75K |
| 2026-08-19 | DAVENPORT FRED B JR | Sell | 7.28K | $606.15 | 4.41M |
| 2026-08-19 | DAVENPORT FRED B JR | Sell | 1.90K | $133.87 | 254.75K |
| 2026-08-19 | DAVENPORT FRED B JR | Sell | 3.86K | $84.36 | 325.46K |
| 2026-08-19 | DAVENPORT FRED B JR | Sell | 1.82K | $164.68 | 300.05K |
| 2026-08-13 | Troendle August J. | Sell | 458 | $600.39 | 274.98K |
| 2026-08-12 | Troendle August J. | Sell | 11.37K | $601.53 | 6.84M |
| 2026-08-11 | McCarthy Cornelius P. III | Sell | 1.14K | $605.37 | 690.12K |
| 2026-08-11 | Troendle August J. | Sell | 17.61K | $605.11 | 10.66M |
| 2026-08-10 | Troendle August J. | Sell | 5.53K | $601.53 | 3.33M |
| 2026-08-07 | McCarthy Cornelius P. III | Buy | 3.86K | $84.36 | 325.46K |
| 2026-08-07 | McCarthy Cornelius P. III | Sell | 795 | $585.07 | 465.13K |
| 2026-08-07 | McCarthy Cornelius P. III | Sell | 3.86K | $84.36 | 325.46K |
| 2026-07-28 | Troendle August J. | Sell | 3.51K | $600.01 | 2.11M |
| 2026-07-28 | BURWIG SUSAN E | Sell | 7.50K | $600.00 | 4.50M |
| 2026-07-27 | Troendle August J. | Sell | 3.73K | $600.85 | 2.24M |
| 2026-06-30 | McCarthy Cornelius P. III | Buy | 28 | — | — |
| 2026-06-30 | McCarthy Cornelius P. III | Sell | 28 | — | — |
| 2026-06-30 | Kraft Robert O. | Buy | 33 | — | — |
| 2026-06-30 | Kraft Robert O. | Sell | 33 | — | — |
| 2026-06-30 | Carley Brian T | Buy | 36 | — | — |
| 2026-06-30 | Carley Brian T | Sell | 36 | — | — |
| 2026-06-01 | Hansman Brad W. | Other | 0 | — | — |
| 2026-06-01 | Hansman Brad W. | Other | 5.00K | — | — |
| 2026-06-01 | Hansman Brad W. | Other | 10.00K | $410.54 | 4.11M |
| 2026-05-28 | EWALD STEPHEN P | Buy | 16.35K | $138.87 | 2.27M |
| 2026-05-28 | EWALD STEPHEN P | Sell | 16.35K | $450.00 | 7.36M |
| 2026-05-28 | EWALD STEPHEN P | Sell | 16.35K | $138.87 | 2.27M |
| 2026-05-15 | Zander Dani S. | Buy | 1.11K | $415.27 | 460.95K |
| 2026-05-15 | McCarthy Cornelius P. III | Buy | 1.11K | $415.27 | 460.95K |
| 2026-05-15 | Kraft Robert O. | Buy | 1.11K | $415.27 | 460.95K |
| 2026-05-15 | Gwadry-Sridhar Femida H. | Buy | 1.11K | $415.27 | 460.95K |
| 2026-05-15 | DAVENPORT FRED B JR | Buy | 1.11K | $415.27 | 460.95K |
| 2026-05-15 | Carley Brian T | Buy | 1.11K | $415.27 | 460.95K |
| 2026-04-24 | Troendle August J. | Buy | 20.00K | $410.54 | 8.21M |
| 2026-04-24 | Troendle August J. | Buy | 10.00K | — | — |
| 2026-04-24 | EWALD STEPHEN P | Buy | 3.50K | $138.87 | 486.05K |
| 2026-04-24 | EWALD STEPHEN P | Sell | 3.50K | $138.87 | 486.05K |
| 2026-04-24 | EWALD STEPHEN P | Buy | 10.00K | $410.54 | 4.11M |
| 2026-04-24 | EWALD STEPHEN P | Buy | 5.00K | — | — |
| 2026-04-24 | BURWIG SUSAN E | Buy | 10.00K | $410.54 | 4.11M |
| 2026-04-24 | BURWIG SUSAN E | Buy | 5.00K | — | — |
| 2026-04-24 | Brady Kevin M. | Buy | 7.00K | $138.87 | 972.09K |
| 2026-04-24 | Brady Kevin M. | Buy | 10.00K | $410.54 | 4.11M |
| 2026-04-24 | Brady Kevin M. | Sell | 7.00K | $138.87 | 972.09K |
| 2026-04-24 | Brady Kevin M. | Buy | 5.00K | — | — |
| 2026-03-31 | McCarthy Cornelius P. III | Buy | 29 | — | — |
| 2026-03-31 | McCarthy Cornelius P. III | Sell | 29 | — | — |
| 2026-03-31 | Kraft Robert O. | Buy | 33 | — | — |
| 2026-03-31 | Kraft Robert O. | Sell | 33 | — | — |
| 2026-03-31 | Carley Brian T | Buy | 36 | — | — |
| 2026-03-31 | Carley Brian T | Sell | 36 | — | — |
| 2026-03-18 | BURWIG SUSAN E | Buy | 12.00K | $166.73 | 2.00M |
| 2026-03-18 | BURWIG SUSAN E | Sell | 12.00K | $166.73 | 2.00M |
| 2026-03-17 | GEIGER JESSE J | Buy | 31.71K | $138.87 | 4.40M |
| 2026-03-17 | GEIGER JESSE J | Sell | 31.71K | $455.30 | 14.44M |
| 2026-03-17 | GEIGER JESSE J | Sell | 31.71K | $138.87 | 4.40M |
| 2026-02-17 | EWALD STEPHEN P | Sell | 3.50K | $138.87 | 486.05K |
| 2026-02-17 | EWALD STEPHEN P | Buy | 3.50K | $138.87 | 486.05K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 713, holders -30 vs prior quarter. Ownership 88.55%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 2.50M | 27.81K | +1.13% | 1.32B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.07M | 1.78M | +614.90% | 1.10B |
| AQR CAPITAL MANAGEMENT LLC | 1.28M | -74.90K | -5.53% | 677.31M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.13M | 11.67K | +1.04% | 600.21M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.03M | 15.75K | +1.56% | 543.79M |
| STATE STREET CORP | 710.89K | 28.67K | +4.20% | 376.48M |
| GEODE CAPITAL MANAGEMENT, LLC | 710.47K | -34.64K | -4.65% | 376.31M |
| WASATCH ADVISORS LP | 636.60K | -137.34K | -17.75% | 337.13M |
| INVESCO LTD. | 579.24K | 1.67K | +0.29% | 306.76M |
| BAILLIE GIFFORD & CO | 473.21K | -29.98K | -5.96% | 250.61M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 429.01K | 33.24K | +8.40% | 227.20M |
| RENAISSANCE TECHNOLOGIES LLC | 415.59K | -89.08K | -17.65% | 220.09M |
| DIMENSIONAL FUND ADVISORS LP | 397.50K | 49.02K | +14.07% | 210.52M |
| MORGAN STANLEY | 317.55K | 29.13K | +10.10% | 168.17M |
| UBS GROUP AG | 303.93K | -36.51K | -10.72% | 160.96M |
| BESSEMER GROUP INC | 282.90K | -2.53K | -0.89% | 149.82M |
| MAWER INVESTMENT MANAGEMENT LTD. | 267.18K | -178.93K | -40.11% | 141.49M |
| EPOCH INVESTMENT PARTNERS, INC. | 266.55K | 125.59K | +89.10% | 141.16M |
| TD ASSET MANAGEMENT INC | 263.87K | 130.82K | +98.32% | 139.74M |
| THRIVENT FINANCIAL FOR LUTHERANS | 256.34K | 24.85K | +10.73% | 135.76M |
| GIVERNY CAPITAL INC. | 253.93K | -2.15K | -0.84% | 134.48M |
| GOLDMAN SACHS GROUP INC | 250.78K | 82.29K | +48.84% | 132.81M |
| MADISON ASSET MANAGEMENT, LLC | 243.50K | -18.79K | -7.16% | 128.96M |
| D. E. SHAW & CO., INC. | 234.54K | -198.06K | -45.78% | 124.21M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 230.56K | 156.90K | +213.02% | 122.10M |
Insights
- Revenue by product
| Period | Value |
|---|---|
| FY2018 | Antiviral And Anti Infective: 76739000.0, Cardiology: 91824000.0, Central Nervous System: 53904000.0, Endocrine: 26002000.0, Medical Devices: 11772000.0, Metabolic: 94128000.0, Oncology: 189026000.0, Other: 161194000.0, Revenue Net: 15100000.0 |
| FY2019 | Antiviral And Anti Infective: 86390000.0, Cardiology: 91258000.0, Central Nervous System: 65391000.0, Direct Revenue: 0.0, Metabolic: 138650000.0, Oncology: 256766000.0, Other: 222514000.0, Reimbursed Out Of Pocket Revenue: 0.0, Revenue Net: 18900000.0 |
| FY2020 | Revenue Net: 15900000.0 |
| FY2021 | Antiviral And Anti Infective: 110976000.0, Cardiology: 119692000.0, Central Nervous System: 121548000.0, Metabolic: 159900000.0, Oncology: 362846000.0, Other: 267415000.0, Revenue Net: 34500000.0 |
| FY2022 | Antiviral And Anti Infective: 118031000.0, Cardiology: 174634000.0, Central Nervous System: 157939000.0, Metabolic: 244682000.0, Oncology: 467796000.0, Other: 296914000.0, Revenue Net: 1459996000.0 |
| FY2023 | Antiviral And Anti Infective: 163312000.0, Cardiology: 193690000.0, Central Nervous System: 160057000.0, Metabolic: 376842000.0, Oncology: 587097000.0, Other: 404844000.0, Revenue Net: 1885842000.0 |
| FY2024 | Antiviral And Anti Infective: 156460000.0, Cardiology: 230454000.0, Central Nervous System: 181977000.0, Metabolic: 457542000.0, Oncology: 651237000.0, Other: 431384000.0 |
| FY2025 | Antiviral And Anti Infective: 134935000.0, Cardiology: 239371000.0, Central Nervous System: 254838000.0, Metabolic: 744957000.0, Oncology: 747585000.0, Other: 408548000.0 |
Insights · Dividends · Forecast · Financials · Learn